# Western Pharma Giants Paid Millions to Russian Distributors Linked to Fraud, Whistleblower Report Says

- URL: https://talkfuse.com/story/western-pharma-giants-paid-millions-to-russian-distributors-linked-to-fraud-whistleblower-report-says/
- Published: 2026-11-02T17:57:14+00:00
- Updated: 2026-11-04T00:55:02+00:00
- Original publisher: The Moscow Times
- Original article: https://www.themoscowtimes.com/2026/11/02/western-pharma-giants-paid-millions-to-russian-distributors-linked-to-fraud-whistleblower-report-says-a94158
- Topics: Europe, Health, Medicine, World

## Key points

- Four drugmakers are accused of paying large bonuses to Russian distributors.
- Many cancer drug tenders reportedly had no competing bidders.
- The report alleges risks of corruption but offers no direct payment records.

## Summary

A whistleblower report alleges that Merck, Eli Lilly, Novartis and AstraZeneca paid unusually large bonuses and rebates to Russian distributors supplying cancer drugs to state hospitals. The payments may have helped sustain high prices and restrict competition in public procurement, while raising questions about whether the companies overlooked signs of corruption.

The reported bonuses and rebates ranged from 15% to 35%, compared with an international average said to rarely exceed 10%. Between 2020 and 2022, R-Pharma won $360 million in contracts for Merck’s Keytruda, and 96% of its bids reportedly had no competitors. Other examples include single-bid contracts for Eli Lilly’s Cyramza and AstraZeneca’s Tagrisso; the companies either declined to comment or did not respond, while R-Pharma denied wrongdoing. The documents do not include direct records of payments to officials, and U.S. regulators declined to comment.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.